{"count": 10, "results": [{"_id": "36444165", "pmid": 36444165, "pmcid": "PMC9836235", "title": "New potential for an old kid on the block: Impact of premorbid metformin use on lactate kinetics, kidney injury and mortality in sepsis and septic shock, an observational study", "journal": "Endocrinol Diabetes Metab", "authors": ["Van Moorter N", "Tackaert T", "De Decker K", "Van Vlem B", "De Neve N"], "date": "2023-01-01T00:00:00Z", "doi": "10.1002/edm2.382", "meta_date_publication": "2023 Jan", "meta_volume": "6", "meta_issue": "1", "meta_pages": "e382", "score": 50283.496, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use was also associated with reduced mortality in @<m>DISEASE_Shock_Septic</m> @DISEASE_MESH:D012772 @@@septic shock@@@. ", "citations": {"NLM": "Van Moorter N, Tackaert T, De Decker K, Van Vlem B, De Neve N. New potential for an old kid on the block: Impact of premorbid metformin use on lactate kinetics, kidney injury and mortality in sepsis and septic shock, an observational study Endocrinol Diabetes Metab. 2023 Jan;6(1):e382. PMID: 36444165", "BibTeX": "@article{36444165, title={New potential for an old kid on the block: Impact of premorbid metformin use on lactate kinetics, kidney injury and mortality in sepsis and septic shock, an observational study}, author={Van Moorter N and Tackaert T and De Decker K and Van Vlem B and De Neve N}, journal={Endocrinol Diabetes Metab}, volume={6}, number={1}, pages={e382}}"}}, {"_id": "37037116", "pmid": 37037116, "title": "AMPK reduces macrophage endotoxin tolerance through inhibition of TGF-beta1 production and its signaling pathway.", "journal": "Int Immunopharmacol", "authors": ["Yin M", "Kim J", "Choi JI", "Bom JS", "Bae HB", "Jeong S"], "date": "2023-05-01T00:00:00Z", "doi": "10.1016/j.intimp.2023.110146", "meta_date_publication": "2023 May", "meta_volume": "118", "meta_issue": "", "meta_pages": "110146", "score": 50240.207, "text_hl": "Therefore, the present study was performed to investigate the mechanism by which the AMPK activator, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, inhibits the development of @<m>DISEASE_Shock_Septic</m> @DISEASE_MESH:D012772 @@@endotoxin@@@ tolerance. ", "citations": {"NLM": "Yin M, Kim J, Choi JI, Bom JS, Bae HB, Jeong S. AMPK reduces macrophage endotoxin tolerance through inhibition of TGF-beta1 production and its signaling pathway. Int Immunopharmacol. 2023 May;118():110146. PMID: 37037116", "BibTeX": "@article{37037116, title={AMPK reduces macrophage endotoxin tolerance through inhibition of TGF-beta1 production and its signaling pathway.}, author={Yin M and Kim J and Choi JI and Bom JS and Bae HB and Jeong S}, journal={Int Immunopharmacol}, volume={118}, pages={110146}}"}}, {"_id": "41025026", "pmid": 41025026, "title": "Donohue syndrome with a homozygous INSR exon 14 deletion: a case report.", "journal": "Oxf Med Case Reports", "authors": ["Almazán Monroy JD", "Valle Martinez AJ", "Milla Salguero SE", "Perdomo Domínguez ES"], "date": "2025-09-28T00:00:00Z", "doi": "10.1093/omcr/omaf183", "meta_date_publication": "2025 Sep", "meta_volume": "2025", "meta_issue": "9", "meta_pages": "omaf183", "score": 50233.812, "text_hl": "Despite treatment with @CHEMICAL_Octreotide @CHEMICAL_MESH:D015282 @@@octreotide@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and @CHEMICAL_maltodextrin @CHEMICAL_MESH:C008315 @@@maltodextrin@@@, the @SPECIES_9606 @@@patient@@@'s condition worsened, leading to @<m>DISEASE_Shock_Septic</m> @DISEASE_MESH:D012772 @@@septic shock@@@, @DISEASE_Disseminated_Intravascular_Coagulation @DISEASE_MESH:D004211 @@@disseminated intravascular coagulation@@@, and @DISEASE_Multiple_Organ_Failure @DISEASE_MESH:D009102 @@@multiple organ failure@@@. ", "citations": {"NLM": "Almazán Monroy JD, Valle Martinez AJ, Milla Salguero SE, Perdomo Domínguez ES. Donohue syndrome with a homozygous INSR exon 14 deletion: a case report. Oxf Med Case Reports. 2025 Sep;2025(9):omaf183. PMID: 41025026", "BibTeX": "@article{41025026, title={Donohue syndrome with a homozygous INSR exon 14 deletion: a case report.}, author={Almazán Monroy JD and Valle Martinez AJ and Milla Salguero SE and Perdomo Domínguez ES}, journal={Oxf Med Case Reports}, volume={2025}, number={9}, pages={omaf183}}"}}, {"_id": "35747014", "pmid": 35747014, "pmcid": "PMC9206834", "title": "Does the Same Hyperlactatemia Cut-Off in the Context of Acute Diseases Hold the Same Meaning in Diabetes Mellitus?", "journal": "Cureus", "authors": ["Vieira IH", "Petrova M", "Moura JP"], "date": "2022-05-20T00:00:00Z", "doi": "10.7759/cureus.25163", "meta_date_publication": "2022 May", "meta_volume": "14", "meta_issue": "5", "meta_pages": "e25163", "score": 50222.84, "text_hl": "In the subgroup with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@DM@@@ and @CHEMICAL_Lactic_Acid @CHEMICAL_MESH:D019344 @@@lactate@@@ of >4 mmol/L (N = 60), the most frequently reported potential contributors included taking @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ simultaneously with factors likely to enhance its accumulation (n = 37), @DISEASE_Sepsis @DISEASE_MESH:D018805 @@@sepsis@@@/@<m>DISEASE_Shock_Septic</m> @DISEASE_MESH:D012772 @@@septic shock@@@ (n = 24), @DISEASE_Ischemia @DISEASE_MESH:D007511 @@@ischemia@@@ (n = 7), and presence of @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@neoplasia@@@ (n = 5). ", "citations": {"NLM": "Vieira IH, Petrova M, Moura JP. Does the Same Hyperlactatemia Cut-Off in the Context of Acute Diseases Hold the Same Meaning in Diabetes Mellitus? Cureus. 2022 May;14(5):e25163. PMID: 35747014", "BibTeX": "@article{35747014, title={Does the Same Hyperlactatemia Cut-Off in the Context of Acute Diseases Hold the Same Meaning in Diabetes Mellitus?}, author={Vieira IH and Petrova M and Moura JP}, journal={Cureus}, volume={14}, number={5}, pages={e25163}}"}}, {"_id": "26775158", "pmid": 26775158, "pmcid": "PMC4715304", "title": "Lactic acidosis and severe septic shock in metformin users: a cohort study", "journal": "Crit Care", "authors": ["Doenyas-Barak K", "Beberashvili I", "Marcus R", "Efrati S"], "date": "2016-01-15T00:00:00Z", "doi": "10.1186/s13054-015-1180-6", "meta_date_publication": "2016 Jan 15", "meta_volume": "20", "meta_issue": "", "meta_pages": "10", "score": 50087.234, "text_hl": "@DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@Lactic acidosis@@@ and severe @<m>DISEASE_Shock_Septic</m> @DISEASE_MESH:D012772 @@@septic shock@@@ in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users: a cohort study", "citations": {"NLM": "Doenyas-Barak K, Beberashvili I, Marcus R, Efrati S. Lactic acidosis and severe septic shock in metformin users: a cohort study Crit Care. 2016 Jan 15;20():10. PMID: 26775158", "BibTeX": "@article{26775158, title={Lactic acidosis and severe septic shock in metformin users: a cohort study}, author={Doenyas-Barak K and Beberashvili I and Marcus R and Efrati S}, journal={Crit Care}, volume={20}, pages={10}}"}}, {"_id": "27792125", "pmid": 27792125, "title": "Impact of Metformin Use on Lactate Kinetics in Patients with Severe Sepsis and Septic Shock.", "journal": "Shock", "authors": ["Park J", "Hwang SY", "Jo IJ", "Jeon K", "Suh GY", "Lee TR", "Yoon H", "Cha WC", "Sim MS", "Carriere KC", "Yeon S", "Shin TG"], "date": "2017-05-01T00:00:00Z", "doi": "10.1097/SHK.0000000000000782", "meta_date_publication": "2017 May", "meta_volume": "47", "meta_issue": "5", "meta_pages": "582-587", "score": 50058.69, "text_hl": "Impact of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use on @CHEMICAL_Lactic_Acid @CHEMICAL_MESH:D019344 @@@Lactate@@@ Kinetics in @SPECIES_9606 @@@Patients@@@ with Severe @DISEASE_Sepsis @DISEASE_MESH:D018805 @@@Sepsis@@@ and @<m>DISEASE_Shock_Septic</m> @DISEASE_MESH:D012772 @@@Septic Shock@@@.", "citations": {"NLM": "Park J, Hwang SY, Jo IJ, Jeon K, Suh GY, Lee TR, Yoon H, Cha WC, Sim MS, Carriere KC, Yeon S, Shin TG. Impact of Metformin Use on Lactate Kinetics in Patients with Severe Sepsis and Septic Shock. Shock. 2017 May;47(5):582-587. PMID: 27792125", "BibTeX": "@article{27792125, title={Impact of Metformin Use on Lactate Kinetics in Patients with Severe Sepsis and Septic Shock.}, author={Park J and Hwang SY and Jo IJ and Jeon K and Suh GY and Lee TR and Yoon H and Cha WC and Sim MS and Carriere KC and Yeon S and Shin TG}, journal={Shock}, volume={47}, number={5}, pages={582-587}}"}}, {"_id": "27154789", "pmid": 27154789, "pmcid": "PMC4859991", "title": "Prognosis of extremely severe lactic acidosis in metformin-treated patients with septic shock: continuous (?) renal replacement therapy in the spotlight!", "journal": "Crit Care", "authors": ["Honore PM", "Spapen HD"], "date": "2016-05-07T00:00:00Z", "doi": "10.1186/s13054-016-1286-5", "meta_date_publication": "2016 May 7", "meta_volume": "20", "meta_issue": "1", "meta_pages": "127", "score": 50054.203, "text_hl": "Prognosis of extremely severe @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@ in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-treated @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Shock_Septic</m> @DISEASE_MESH:D012772 @@@septic shock@@@: continuous (?) ", "citations": {"NLM": "Honore PM, Spapen HD. Prognosis of extremely severe lactic acidosis in metformin-treated patients with septic shock: continuous (?) renal replacement therapy in the spotlight! Crit Care. 2016 May 7;20(1):127. PMID: 27154789", "BibTeX": "@article{27154789, title={Prognosis of extremely severe lactic acidosis in metformin-treated patients with septic shock: continuous (?) renal replacement therapy in the spotlight!}, author={Honore PM and Spapen HD}, journal={Crit Care}, volume={20}, number={1}, pages={127}}"}}, {"_id": "26260849", "pmid": 26260849, "title": "Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D-galactosamine-induced fulminant hepatitis.", "journal": "Mol Med Rep", "authors": ["Gong X", "Duan R", "Ao JE", "Ai Q", "Ge P", "Lin L", "Zhang L"], "date": "2015-10-01T00:00:00Z", "doi": "10.3892/mmr.2015.4206", "meta_date_publication": "2015 Oct", "meta_volume": "12", "meta_issue": "4", "meta_pages": "6384-90", "score": 50049.86, "text_hl": "Previous studies have demonstrated that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ attenuates @<m>DISEASE_Shock_Septic</m> @DISEASE_MESH:D012772 @@@endotoxic hepatitis@@@, however the mechanisms remain unclear. ", "citations": {"NLM": "Gong X, Duan R, Ao JE, Ai Q, Ge P, Lin L, Zhang L. Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D-galactosamine-induced fulminant hepatitis. Mol Med Rep. 2015 Oct;12(4):6384-90. PMID: 26260849", "BibTeX": "@article{26260849, title={Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D-galactosamine-induced fulminant hepatitis.}, author={Gong X and Duan R and Ao JE and Ai Q and Ge P and Lin L and Zhang L}, journal={Mol Med Rep}, volume={12}, number={4}, pages={6384-90}}"}}, {"_id": "25407884", "pmid": 25407884, "title": "Anti-inflammatory effects of four potential anti-endotoxaemic drugs assessed in vitro using equine whole blood assays.", "journal": "J Vet Pharmacol Ther", "authors": ["Bauquier JR", "Tudor E", "Bailey SR"], "date": "2015-06-01T00:00:00Z", "doi": "10.1111/jvp.12182", "meta_date_publication": "2015 Jun", "meta_volume": "38", "meta_issue": "3", "meta_pages": "290-6", "score": 50042.22, "text_hl": "In this study, four compounds with potential anti-@<m>DISEASE_Shock_Septic</m> @DISEASE_MESH:D012772 @@@endotoxic@@@ effects, namely @CHEMICAL_Rolipram @CHEMICAL_MESH:D020889 @@@rolipram@@@, @CHEMICAL_Azithromycin @CHEMICAL_MESH:D017963 @@@azithromycin@@@, @CHEMICAL_ethyl_pyruvate @CHEMICAL_MESH:C046522 @@@ethyl pyruvate@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, were investigated in vitro using @SPECIES_9796 @@@equine@@@ whole blood stimulated with bacterial @CHEMICAL_Lipopolysaccharides @CHEMICAL_MESH:D008070 @@@lipopolysaccharide@@@. ", "citations": {"NLM": "Bauquier JR, Tudor E, Bailey SR. Anti-inflammatory effects of four potential anti-endotoxaemic drugs assessed in vitro using equine whole blood assays. J Vet Pharmacol Ther. 2015 Jun;38(3):290-6. PMID: 25407884", "BibTeX": "@article{25407884, title={Anti-inflammatory effects of four potential anti-endotoxaemic drugs assessed in vitro using equine whole blood assays.}, author={Bauquier JR and Tudor E and Bailey SR}, journal={J Vet Pharmacol Ther}, volume={38}, number={3}, pages={290-6}}"}}, {"_id": "17058569", "pmid": 17058569, "title": "Metabolic emergencies in diabetes.", "journal": "J Indian Med Assoc", "authors": ["Mukherjee AK", "Chowdhury MB"], "date": "2006-05-01T00:00:00Z", "meta_date_publication": "2006 May", "meta_volume": "104", "meta_issue": "5", "meta_pages": "244-6, 248", "score": 50035.035, "text_hl": "@DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@Lactic acidosis@@@ is extremely rare; may be compounded with comorbidities like tissue @DISEASE_Hypoxia @DISEASE_MESH:D000860 @@@hypoxia@@@, @<m>DISEASE_Shock_Septic</m> @DISEASE_MESH:D012772 @@@septic shock@@@, @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@--@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ usage inadvertently may precipitate the condition.", "citations": {"NLM": "Mukherjee AK, Chowdhury MB. Metabolic emergencies in diabetes. J Indian Med Assoc. 2006 May;104(5):244-6, 248. PMID: 17058569", "BibTeX": "@article{17058569, title={Metabolic emergencies in diabetes.}, author={Mukherjee AK and Chowdhury MB}, journal={J Indian Med Assoc}, volume={104}, number={5}, pages={244-6, 248}}"}}]}